Skip to content

BYSI

BeyondSpring Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.73
+2.95%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-55.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 6, 2026Qiu Min · officer: Chief Executive OfficerA-Award100,000$1.75
Jul 6, 2026Majeti Jiangwen · directorA-Award100,000$1.75
Apr 8, 2026Kirkby Matthew · directorA-Award23,902$1.64
Apr 3, 2026Fabbio Patrick · directorA-Award22,165$1.64
Apr 3, 2026Majeti Jiangwen · directorA-Award21,730$1.64
Apr 3, 2026Delaney Brendan · directorA-Award20,427$1.64
Apr 3, 2026Lu Yingjuan June · officer: Chief Scientific OfficerA-Award17,840$1.64
Apr 3, 2026Huang Lan · director, 10 percent owner, officer: Chief Executive OfficerA-Award11,514$1.80
Apr 3, 2026Xu Sihai · directorA-Award18,689$1.64
Oct 20, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale45,513$1.76
Oct 20, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale85,798$1.72
Oct 15, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale17,960$1.65
Oct 15, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale107,361$1.70
Oct 15, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale28,495$1.65
Oct 10, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale7,507$1.77
Oct 10, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale3,979$1.81
Oct 10, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale2,390$1.77
Oct 7, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale600$1.76
Oct 7, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale2,100$1.79
Oct 7, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale17,500$1.78
Oct 2, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale600$1.73
Oct 2, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale4,464$1.81
Oct 2, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale2,601$1.80
Sep 29, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale700$1.66
Sep 29, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale500$1.75
Sep 29, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale600$1.68
Sep 24, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale5,410$1.83
Sep 24, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale4,106$1.72
Sep 24, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale2,256$1.68
Sep 19, 2025Decheng Capital China Life Sciences USD Fund III, L.P. · 10 percent ownerSale2,304$1.83
Institutional positioning

13F filings over the trailing two quarters

New 10Increased 11Reduced 8Sold out 1
FilerActionSharesFiled
DECHENG CAPITAL LLCUnchanged3,800,702May 13, 2026
Decheng Capital LLCUnchanged3,800,702Aug 14, 2026
BlackRock, Inc.Increased672,915Aug 7, 2026
BLACKROCK, INC.Reduced649,462May 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased626,457Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position607,934May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased375,371May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced367,740Aug 12, 2026
STATE STREET CORPUnchanged231,120May 15, 2026
STATE STREET CORPUnchanged231,120Aug 7, 2026
VANGUARD FIDUCIARY TRUST COIncreased181,196Aug 13, 2026
VANGUARD FIDUCIARY TRUST CONew Position179,925May 8, 2026
NORTHERN TRUST CORPUnchanged69,268May 14, 2026
UBS Group AGIncreased63,032Aug 13, 2026
NORTHERN TRUST CORPReduced62,024Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 6, 2026